Oleg Nodelman
@Ecor1 Capital, Llc
Latest period2024 - Q3ReportedManaged Assets$2.922BTotal holdings63
Assets growth rate-10.62%Assets growth rate (2-Q avg)-13.97%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Ecor1 Capital, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 63 positions.
Assets under management
The assets under management (AUM) of Ecor1 Capital, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 2.922B in assets, with a quarterly growth rate of -10.62% and a 2-quarter average growth rate of -13.97%. The portfolio is managed by Oleg Nodelman, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
ORICOric Pharmaceuticals Inc
| 1.2% | $35.035M 3.418M shares@ $10.25 avg price | |
RNAAvidity Biosciences Inc
| 1.2% | $34.795M 757,576 shares@ $45.94 avg price | |
EWTXEdgewise Therapeutics Inc
| 1.15% | $33.373M 1.25M shares@ $26.7 avg price | |
MBXMbx Biosciences Inc
| 1.05% | $30.548M 1.176M shares@ $25.99 avg price | New Position |
NMRANeumora Therapeutics Inc.
| 0.94% | $27.364M 2.071M shares@ $13.22 avg price | |
CRGXCargo Therapeutics Inc
| 0.93% | $27.122M 1.47M shares@ $18.45 avg price | |
ADAPAdaptimmune Therapeutics Plc
| 0.9% | $26.045M 27.404M shares@ $0.96 avg price | |
TECXTectonic Therapeutic Inc
| 0.89% | $25.729M 849,143 shares@ $30.31 avg price | |
TCRXTscan Therapeutics Inc
| 0.86% | $24.9M 5M shares@ $4.98 avg price | |
VYGRVoyager Therapeutics Inc
| 0.79% | $22.918M 3.918M shares@ $5.85 avg price |